Company Filing History:
3 out of 3 
3 out of 3 
2 out of 528 
Years Active: 1998-2013
Title: Kevin Jon Williams: Innovator in Cancer Diagnostics
Introduction
Kevin Jon Williams, an accomplished inventor based in Wynnewood, PA, has made significant contributions to the field of medical diagnostics. He holds 15 patents, focusing primarily on innovations that enhance the detection and diagnosis of cancer through the use of thrombospondin fragments.
Latest Patents
Among his latest inventions are two pivotal patents that center around thrombospondin fragments and their applications in cancer diagnostics. The first patent describes the use of these fragments, found in plasma, as diagnostic methods, method calibrators, indicators, immunogens, and analytes that demonstrate substantial clinical utility. It emphasizes their detection in plasma or other bodily fluids, particularly for cancer diagnostics. The second patent builds on this innovative approach, detailing clinical assays for the same thrombospondin fragments to improve the detection, diagnosis, and evaluation of cancer.
Career Highlights
Throughout his career, Kevin has worked at various esteemed organizations, including Talaria Therapeutics, Inc. His extensive experience in the medical research field has propelled him into the spotlight as a leading inventor specializing in cancer diagnostics.
Collaborations
Kevin has collaborated with notable professionals in his field, including Ira A. Tabas and Scott L. Schissel. Their combined expertise contributes to advancing research and developing impactful diagnostic technologies.
Conclusion
Kevin Jon Williams's innovative work in cancer diagnostics through his patents showcases his commitment to improving healthcare. His contributions not only enhance the understanding of thrombospondin fragments but also pave the way for more effective diagnostic methods, ultimately aiming to save lives.